Godavari Biorefineries / Q4-FY26

Read the quarter in context.

A source-linked quarter view: reported numbers, management language, guidance, and the risks that should carry forward.

Research layer active

ConCallIQ research layer

Signal, with the source still visible.

Use the controls below to narrow the view, then follow the evidence into the next layer of context.

Positive2026-05-15Back to GODAVARIB

Revenue

₹564 Cr

verified against source

Revenue YoY

reported change

EBITDA

₹92 Cr

latest reported figure

Source

screener in

record provenance

Actual signal trajectory

Where this quarter sits.

source records only
PAT (₹ Cr)PositiveWatchNegative
1 actual records
Actual quarterly PAT (₹ Cr) trajectoryReported values plotted by quarter. Hover or focus a point for its quarter, value, and source sentiment.Q4 FY26: 52.9 · Positive source sentiment · 2026-05-15Q4 FY2652.952.9
Values are taken from the available verified source records; sentiment color is a separate source-read indicator.

Quarter read

What the record says.

Godavari Biorefineries delivered a strong Q4 FY26 with revenue from operations of ₹564 crore and EBITDA of ₹92 crore (16.2% margin), driven by record cane crushing of 2.5 million tons and improved sugar operations. PAT surged to ₹52.9 crore from a loss in Q3, reflecting operational leverage and a 32% reduction in finance costs after repaying ₹240 crore debt. The bio-based chemicals segment saw margins double QoQ to 16.2%, though specialty mix dipped to 61% as management opportunistically ran ethyl acetate. The 200 KPD grain distillery (60 million liters annual capacity) is on track for commissioning trials in June 2026. Management guided for stronger bio-chemical demand in FY27 due to narrowing fossil-renewable price gaps. Key risk: ethanol price revision remains uncertain, and the grain distillery could face margin pressure if maize prices stay elevated.

Colored figures show movement against the previous available record.

Guidance to track

  • The 200 KPD grain-based distillery will begin commissioning trials next month, adding 60 million liters of annual ethanol capacity.
  • Management expects improved market penetration and demand for bio-based chemicals starting Q1 FY27 due to narrowing fossil-renewable price gaps.
  • Management expects the government to revise ethanol prices upward given rising sugarcane costs and higher energy prices, though no timeline provided.

Risks flagged

  • Government has not revised ethanol prices despite rising sugarcane costs, pressuring margins. Management could not provide a timeline for any revision.
  • Maize-based ethanol prices are frozen while maize trades near MSP, potentially compressing gross spreads when the new distillery commissions.
  • West Asia crisis has increased logistics freight and raw material volatility, impacting the bio-based chemical segment in Q4.

Key quotes

  • The West Asia crisis suddenly transports us into the future when we see a world in which fossil resources are scarce and that environment is currently real for us.
  • Our energy is about 85% from bagasse as a fuel and about 15% from coal. These costs of energy have more or less remained stable.
  • The strategic objective of bio specialty chemicals remain and if there is an opportunity to do ethyl acetate business if margins are there we will do that.

Research modules

Go one layer deeper.